Compared to the LBL group, the levels of the 6 markers were with no significance in liver cancer, esophageal cancer, and gastric cancer, however, in ovarian cancer, 4 markers (CKAP2, DEPDC1B, DPP4, and TCP11L2) also showed a significant lower level. This evidence concerns the gene DEPDC1B and liver cancer.